Ads
related to: flu shots
Search results
COVID Still Deadlier Than the Flu -- But the Gap Is Narrowing
MedPage Today· 2 days agoPatients hospitalized with COVID-19 were more likely to die than those hospitalized with influenza...
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 1 day agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 6 days agoThe deal encompasses the commercialization of a combined COVID-19 and flu shot, marking a pivotal...
How Nintendo Switch Is Being Used By A New Generation Of Therapists
Nintendo Life· 6 days agoMay is Mental Health Awareness Month and we'll be running several features focused on how video...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 6 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
NYSOFA releases county data from first-ever statewide Needs Assessment Survey of New Yorkers 60+
Plattsburgh Press-Republican· 1 day agoMay is Older Americans Month and the New York State Office for the Aging (NYSOFA) released...
SI swimsuit celebrates 60th anniversary with legends cover
ABC News· 2 days agoSports Illustrated Swimsuit is celebrating 60 years with not one, but seven amazing covers. The...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 days agoThe deal allows Sanofi to develop combination vaccines using Nuvaxovid, including a flu/Covid shot....
One of the most shorted stocks on the market just leapt 99%, putting a ‘rib-crunching’ squeeze on...
Fortune· 6 days agoShares of the vaccine maker soared 99% Friday, after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu</ ...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 7 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
